Lyra Therapeutics
LYRA
LYRA
57 hedge funds and large institutions have $3.23M invested in Lyra Therapeutics in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
32% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 19
42% less capital invested
Capital invested by funds: $5.55M → $3.23M (-$2.32M)
Holders
57
Holding in Top 10
–
Calls
$7K
Puts
$4K
Top Buyers
| 1 | +$16.4K | |
| 2 | +$14.4K | |
| 3 | +$5.85K | |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$5.85K |
| 5 |
Jane Street
New York
|
+$5.56K |
Top Sellers
| 1 | -$72.7K | |
| 2 | -$70.6K | |
| 3 | -$23.4K | |
| 4 |
Morgan Stanley
New York
|
-$19.1K |
| 5 |
JPMorgan Chase & Co
New York
|
-$12.6K |
